Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. - Wikidata - awgldk - TriplyDB

Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment.

Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment.

http://www.wikidata.org/entity/Q34015932

about

Insulin: an emerging treatment for Alzheimer's disease dementia?Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?Using genetics to enable studies on the prevention of Alzheimer's disease Effects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain.Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND.Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.Changes in physical performance in older women according to presence and treatment of diabetes mellitus.Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Insulin Resistance-Associated Interhemispheric Functional Connectivity Alterations in T2DM: A Resting-State fMRI Study Thalamic resting-state functional connectivity: disruption in patients with type 2 diabetes.Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment.A novel thiazolidinediones ATZD2 rescues memory deficits in a rat model of type 2 diabetes through antioxidant and antiinflammation.Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients.Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis

P2860

Q26827376-93D3DC21-A704-4196-81B7-22D2D82FBBEB Q27008997-473C27DF-145A-4D21-984E-C5D5B4FE51ED Q33603286-BAA55202-495D-4A17-9A8D-8F678BA5F40F Q34038890-8D6551F7-E431-4CFA-A92F-E91FA2B9BDB7 Q35073600-FB7DD83A-0F4D-4B56-A12F-0D00046604A2 Q36044265-85B47766-3019-430C-B970-EE5C96DBB32C Q36477870-020047E0-B3AD-456E-9E7F-0D2F1093498A Q37107280-9B943C0A-F5B7-4D0D-B34C-BBB7899BB441 Q37158071-EF0BB59E-7638-4A39-82FA-51DD47ED0BD1 Q37307513-4BE980B5-E2C2-4BD5-ADFF-DB0EB0EF550F Q37878981-046C2251-2644-420E-A066-7D5C738EFCDA Q38823805-C9544DAC-98B0-49A0-B701-B22AE0879DF4 Q39042377-CA7C8948-B295-4883-BF01-E55B2914241A Q40638812-90B7D6B6-D78C-4BFD-ACA2-D394D5640B3F Q40792050-B29FAA18-7AA1-4EE2-92A7-29CB92B9EFE2 Q46945027-112A0706-073D-4690-B38A-342BA5F5A654 Q47136653-BD22B909-C14B-45D5-854D-62E22B8C39C4 Q55214530-650792C2-1442-47D7-BE00-C82375F61502 Q58696775-A21C5709-945C-41DC-981F-DFDFCAF318C9

P2860

Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment.

http://www.wikidata.org/entity/Q34015932

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@ast

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@en

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@nl

type

label

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@ast

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@en

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@nl

prefLabel

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@ast

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@en

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@nl

P1433

Q34015932-1B56C363-D04C-4D13-9EC8-3B182CE47587

P1476

Q34015932-4E4CB72B-D121-4C0B-BFA3-0E37723FC733

P2093

Q34015932-1C567287-8DEE-4C45-A80E-A08BB14629AF

Q34015932-4B1F71C3-EF84-4C5F-A90C-71BDD99DDEB5

Q34015932-5C4DEAE9-855E-4D08-A5B0-207091C3F4B9

Q34015932-9B7D624D-C875-43E7-B972-FCAA569BAF40

Q34015932-A03DAEBA-C2EB-424F-86B1-12C259F001BA

Q34015932-A7136AF6-5DFB-4C3E-B439-7E1F17F1E7DC

Q34015932-C13E0557-4239-4439-8B56-F4B3D848984E

Q34015932-C76F51C6-E6BC-478D-A7F7-822BFE31E8C5

Q34015932-E242EBF7-7652-4673-927B-5C39462D1F25

P2860

Q34015932-01DA2314-F7DB-403F-8201-4179676E2F5F

Q34015932-05F3B970-D05E-4F05-B249-CD859D055D8A

Q34015932-09C20041-B399-4229-A07A-30C7AF142194

Q34015932-0FAF972C-6D11-4887-BEFA-35349971D6AB

Q34015932-13716D29-3B4F-4494-84B3-177971EFCFA7

Q34015932-20555341-3BB8-4A37-997F-149295A6409F

Q34015932-3023DADF-8194-466E-BD94-623C8BA55DE2

Q34015932-341D880A-DB8F-4EC1-B98E-62B857DC999C

Q34015932-3BB40545-B28B-475C-A098-18817E730E78

Q34015932-52BB3732-B40A-49F7-A4CA-B9346BE9358B

P304

Q34015932-6258FA3A-8EC3-4D0D-9235-E174F672CE2F

P31

Q34015932-4CF44C09-6696-45AF-B35A-C69ECDD7F9F2

P356

Q34015932-C50F7F78-36A6-4443-888F-CA1D253F663A

P407

Q34015932-7FF20D72-7712-4BA8-AA62-829652A9896F

P433

Q34015932-4EEAA886-EC9C-477D-8517-6D2FF7B80529

P478

Q34015932-65A447C0-84FF-42AF-A18F-923E8F6BB316

P50

Q34015932-E6168466-2481-4549-B1B9-29468D5B38E6

P577

Q34015932-CB39D838-A47A-456E-B7DB-A9E1DEC81D14

P5875

Q34015932-3476EADB-4891-4591-96A4-8C23B6A0064A

P698

Q34015932-0B1A63D7-A49A-4598-BE9B-CA38C23303BA

P921

Q34015932-A8BEA371-E1C7-40B7-BD32-3AD7978D77AA

P932

Q34015932-B985D64C-0BED-4DD8-9172-B3F2632B3B65

P356

P1433

P1476

Rosiglitazone and cognitive st ...... and mild cognitive impairment.

@en

P2093

Angela M Abbatecola

http://www.w3.org/2001/XMLSchema#string

Anna M Molinari

http://www.w3.org/2001/XMLSchema#string

Federico Cacciapuoti

http://www.w3.org/2001/XMLSchema#string

Giuseppe Paolisso

http://www.w3.org/2001/XMLSchema#string

Luigi DiCioccio

http://www.w3.org/2001/XMLSchema#string

Luigi Mansi

http://www.w3.org/2001/XMLSchema#string

Michele Cioffi

http://www.w3.org/2001/XMLSchema#string

Pierfrancesco Rambaldi

http://www.w3.org/2001/XMLSchema#string

Raffaele Canonico

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

Mild cognitive impairment as a diagnostic entity

Tracking cognitive functioning over time: ten-year longitudinal data from a community-based study.

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

Association of duration and severity of diabetes mellitus with mild cognitive impairment.

Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes.

P304

1706-1711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-2030

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizia Lattanzio

P577

2010-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43534787

http://www.w3.org/2001/XMLSchema#string

P698

20435794

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2909046

http://www.w3.org/2001/XMLSchema#string